top of page
Horizon Revenue Solutions Logo

UHC Adult Allergy Testing: Covered Indications and Unit Limits

6 days ago
2 min read

Updated: 3 days ago

UnitedHealthcare’s November commercial bulletin expands consideration for adult serum immunoglobulin E (IgE) testing to chronic rhinosinusitis with nasal polyps and IgE-mediated food allergy, effective September 1, 2026 in California. Allergy, ENT and pulmonology offices should check the current policy before reviewing affected claims. The policy covers Commercial and Individual Exchange plans; this article does not extend it to Medicare or Medicaid.


A focused allergy-claim checklist


  • Confirm the patient’s product, age, test code and date of service.

  • Match the test ordered and performed to the clinical documentation and billed units.

  • Check the current policy version and relevant prior utilization.

  • Separate coding corrections from reimbursement disputes, retaining the payer’s response and filing deadline.


These are Horizon’s recommended workflow checks. Keep the clinician’s testing decision separate from the billing review; a reimbursement rule is not an instruction to order or substitute a test.


Which adult tests need a closer look?


For patients age 20 or older, CPT 82785 is limited to four listed indications: moderate-to-severe asthma, signs or symptoms of allergic bronchopulmonary aspergillosis, chronic rhinosinusitis with nasal polyps, and IgE-mediated food allergy. The November bulletin describes the expanded indications; other states have specified timing exceptions.


For specific-IgE codes 86003 and 86008, the current policy allows consideration of up to 29 units per 365 days from the initial service date, separately for each code. Its frequency rule is member-based across providers. Do not describe this as a calendar-year reset or a newly effective November unit limit. The policy history records a November 6 revision without detailing every change.


How should staff review a denied claim?


Start with the remittance explanation and original claim, not a general note saying “allergy testing denied.” A diagnosis-related denial and a frequency-related denial need different supporting evidence. Ask the payer which rule and policy version it applied when the explanation is unclear.


For an ENT encounter involving nasal polyps, for example, the billing reviewer should compare the actual test and documented indication with the applicable criteria. Staff should not add a diagnosis merely to obtain payment. If the clinical record is incomplete or inconsistent, send the question to the responsible clinician before changing the claim.


For a utilization issue, compare the office’s records with the payer’s explanation of prior services. A clean local ledger does not establish that no other provider billed testing. Request clarification through the plan’s permitted process and retain the response with the claim.


Does meeting the policy guarantee payment?


No. Benefits, contracts and other applicable policies can affect reimbursement. These adult provisions should not be applied to pediatric testing without checking the relevant requirements.


Horizon recommends documenting the disputed issue, supporting records, next action and owner in your existing billing workflow. Correct a factual claim error when appropriate; use the payer’s dispute process when the submitted information is accurate but adjudication appears inconsistent. Avoid automatically resubmitting every older denial, and track the outcome so repeated errors can be addressed.


How Horizon Can Help With Allergy-Testing Denials


Horizon’s coding review and denial follow-up services can help investigate testing claims and reimbursement discrepancies using your practice’s existing software. Call (408) 444-8845 or request a complimentary billing review to identify recurring allergy-testing claim problems.

Comments


bottom of page